Total Payments
$8,980
2024 Payments
$903.76
Companies
56
Transactions
435
Medicare Patients
2,686
Medicare Billing
$423,063
Payment Breakdown by Category
Food & Beverage$8,844 (98.5%)
Education$136.28 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,844 | 431 | 98.5% |
| Education | $136.28 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,100 | 85 | $0 (2024) |
| PFIZER INC. | $999.33 | 40 | $0 (2024) |
| Novo Nordisk Inc | $991.48 | 52 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $620.92 | 36 | $0 (2023) |
| Allergan, Inc. | $564.20 | 14 | $0 (2020) |
| GlaxoSmithKline, LLC. | $481.78 | 24 | $0 (2024) |
| Lilly USA, LLC | $463.24 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $296.83 | 7 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $233.25 | 10 | $0 (2022) |
| Gilead Sciences, Inc. | $205.15 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $903.76 | 58 | ABBVIE INC. ($246.41) |
| 2023 | $866.91 | 56 | ABBVIE INC. ($278.93) |
| 2022 | $1,177 | 47 | ABBVIE INC. ($323.63) |
| 2021 | $1,288 | 65 | AbbVie Inc. ($250.70) |
| 2020 | $687.92 | 35 | Novo Nordisk Inc ($255.77) |
| 2019 | $2,333 | 83 | Allergan Inc. ($413.32) |
| 2018 | $1,170 | 59 | Novartis Pharmaceuticals Corporation ($257.41) |
| 2017 | $552.62 | 32 | PFIZER INC. ($184.52) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Obesity | ||||||
| 11/04/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: PAIN | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Gastroenterology | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PAIN | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 445 | 882 | $112,453 | $56,515 |
| 2022 | 12 | 669 | 1,624 | $174,322 | $109,280 |
| 2021 | 15 | 722 | 1,760 | $185,704 | $118,278 |
| 2020 | 15 | 850 | 2,039 | $211,250 | $138,990 |
Total Patients
2,686
Total Services
6,305
Medicare Billing
$423,063
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 518 | $63,752 | $37,449 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 143 | $26,949 | $9,418 | 34.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $8,385 | $4,156 | 49.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 35 | $4,912 | $2,553 | 52.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 24 | $4,200 | $938.96 | 22.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 32 | 32 | $640.00 | $570.56 | 89.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 32 | 32 | $640.00 | $570.56 | 89.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 24 | 28 | $2,500 | $393.82 | 15.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $300.00 | $294.00 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 25 | $175.00 | $171.50 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 1,112 | $120,096 | $83,159 | 69.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 62 | 62 | $15,500 | $7,726 | 49.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 41 | 44 | $22,000 | $6,020 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 79 | $5,767 | $3,920 | 68.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 20 | $2,800 | $2,134 | 76.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $2,200 | $1,613 | 73.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 62 | 62 | $1,240 | $1,131 | 91.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 60 | 60 | $1,200 | $1,058 | 88.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 29 | 29 | $956.00 | $837.56 | 87.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 47 | 58 | $1,450 | $820.97 | 56.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $700.00 | $686.50 | 98.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 44 | 59 | $413.00 | $174.69 | 42.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 1,201 | $129,652 | $90,474 | 69.8% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 37 | 40 | $20,000 | $5,666 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $11,000 | $5,402 | 49.1% |
About Dr. Mamoon Rasheed, MD
Dr. Mamoon Rasheed, MD is a Internal Medicine healthcare provider based in Rockville Centre, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760448468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mamoon Rasheed, MD has received a total of $8,980 in payments from pharmaceutical and medical device companies, with $903.76 received in 2024. These payments were reported across 435 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($8,844).
As a Medicare-enrolled provider, Rasheed has provided services to 2,686 Medicare beneficiaries, totaling 6,305 services with total Medicare billing of $423,063. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Rockville Centre, NY
- Active Since 04/22/2006
- Last Updated 12/09/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760448468
Products in Payments
- UBRELVY (Drug) $705.12
- ENTRESTO (Drug) $587.48
- VRAYLAR (Drug) $571.10
- ELIQUIS (Drug) $542.72
- Ozempic (Drug) $378.56
- TRELEGY ELLIPTA (Drug) $332.28
- CHANTIX (Drug) $278.13
- NURTEC ODT (Drug) $276.66
- MOUNJARO (Drug) $257.46
- LINZESS (Drug) $238.98
- XARELTO (Drug) $194.56
- Wegovy (Drug) $190.60
- RYBELSUS (Drug) $178.88
- DUPIXENT (Biological) $174.01
- Velphoro (Drug) $151.67
- CHARTIS CATHETER (Device) $142.86
- QULIPTA (Drug) $132.09
- COLOGUARD (Device) $121.77
- WATCHMAN (Device) $120.64
- Xultophy 100/3.6 (Drug) $118.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rockville Centre
Louis Saffran, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452
Charles Mitgang, M.d, M.D
Internal Medicine — Payments: $30,416
Internal Medicine $30,416
Dr. Farid Shahkoohi, M.d, M.D
Internal Medicine — Payments: $29,031
Internal Medicine $29,031
Thierry Duchatellier, Md, MD
Internal Medicine — Payments: $18,330
Internal Medicine $18,330
Ihor Magun, M.d, M.D
Internal Medicine — Payments: $17,499
Internal Medicine $17,499
Daniel Kurbanov, M.d, M.D
Internal Medicine — Payments: $3,719
Internal Medicine $3,719